Company profile: Keyence
1.1 - Company Overview
Company description
- Provider of sensors (photoelectric, fiber optic, laser, inductive proximity, vision), measurement sensors (laser profilers, displacement sensors, optical micrometers), machine vision systems, barcode readers, laser markers, process sensors (flow, pressure, temperature), safety equipment (light curtains, laser scanners, interlock switches), and digital/laser microscopes for factory automation and manufacturing.
Products and services
- Machine Vision: Engineers industrial-grade vision sensors and machine vision systems for automated inspection and quality control in factory automation across worldwide manufacturing industries, emphasizing reliability and innovation
- Sensors: Supplies modular photoelectric, fiber optic, laser, inductive proximity, and vision sensors for various industrial applications, aligning with factory automation demands from every manufacturing industry
- Measurement Sensors: Delivers metrology-grade laser profilers, displacement sensors, and optical micrometers for precise measurement tasks within factory automation across industrial applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Keyence
Intelligent BioSystems
HQ: United States
Website
- Description: Provider of an advanced DNA sequencing system, focused on commercialization. Founded in 2005 by Drs. Steven J. Gordon and Jingyue Ju, the company builds on Dr. Gordon’s prior role founding Intelligent Automation Systems, which delivered key instrumentation solutions that helped complete the Human Genome Project.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intelligent BioSystems company profile →
Sepax Technologies
HQ: United States
Website
- Description: Provider of chromatography columns and resins for biomolecule separation and analysis, including ion exchange (Proteomix IEX), hydrophobic interaction (Proteomix HIC Butyl), size exclusion for ADCs and other biomolecules (Monomix MC SEC resins; Zenix-C SEC), reverse phase for DAR analysis (Proteomix RP-1000), and weak cation exchange for monoclonal antibodies (Antibodix WCX), plus method development services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sepax Technologies company profile →
ChemConnection
HQ: The Netherlands
Website
- Description: Provider of pharmaceutical ingredients and nanomedicines development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ChemConnection company profile →
Rebus Biosystems
HQ: United States
Website
- Description: Provider of spatial omics tools: Rebus Esper for single-cell data at subcellular resolution; Esper High Fidelity assay for spatial transcriptomics (up to 30 custom genes without barcoding or enzymatic amplification); Esper High Plex assay enabling analysis of 1230 gene panels; SAO microscopy enhancing resolution without sacrificing throughput; plus the Esper Service Program providing processed gene images and a spatially annotated CellxFeature matrix.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rebus Biosystems company profile →
PathogenDx
HQ: United States
Website
- Description: Provider of RT-PCR and DNA microarray-based pathogen detection solutions, including assays for SARS-CoV-2 genes and variants (DetectX-Rv, DetectX-Cv), environmental SARS-CoV-2 screening (EnviroX-Rv), a UTI panel detecting 26 pathogens and 12 antibiotic resistance markers (D3 Array-UTI), and semi-quantitative fungal and bacterial assays (QuantX Fungal, QuantX Bacterial).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PathogenDx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Keyence
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Keyence
2.2 - Growth funds investing in similar companies to Keyence
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Keyence
4.2 - Public trading comparable groups for Keyence
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →